Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
Bioinformatics (Oxford, England)|September 3, 2016
Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorizationMuhammad Ammad-Ud-Din, Suleiman A Khan, Disha Malani, et al.
Journal of Chemical Information and Modeling|July 22, 2014
Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorizationMuhammad Ammad-ud-din, Elisabeth Georgii, Mehmet Gönen, et al.
Translational Oncology|February 2, 2021
STRN-ALK rearranged pediatric malignant peritoneal mesothelioma - Functional testing of 527 cancer drugs in patient-derived cancer cellsAstrid Murumägi, Daniela Ungureanu, Mariliina Arjama, et al.
Plos One|December 11, 2012
Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcomaJanne Nordberg, John Patrick Mpindi, Kristiina Iljin, et al.
BMC Genomics|March 30, 2011
A cell spot microarray method for production of high density siRNA transfection microarraysJuha K Rantala, Rami Mäkelä, Anna-Riina Aaltola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growthKristiina Iljin, Kirsi Ketola, Paula Vainio, et al.
Molecular Oncology|October 24, 2013
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growthSuvi-Katri Leivonen, Kristine Kleivi Sahlberg, Rami Mäkelä, et al.
Plos One|September 24, 2013
Plasticity of blood- and lymphatic endothelial cells and marker identificationJohannes Keuschnigg, Sirkku Karinen, Kaisa Auvinen, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Carcinogenesis|May 22, 2013
Aneuploidy facilitates oncogenic transformation via specific genetic alterations, including Twist2 upregulationGunilla Högnäs, Saara Hämälistö, Kirsi Rilla, et al.
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
Bioinformatics (Oxford, England)|September 3, 2016
Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorizationMuhammad Ammad-Ud-Din, Suleiman A Khan, Disha Malani, et al.
Journal of Chemical Information and Modeling|July 22, 2014
Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorizationMuhammad Ammad-ud-din, Elisabeth Georgii, Mehmet Gönen, et al.
Translational Oncology|February 2, 2021
STRN-ALK rearranged pediatric malignant peritoneal mesothelioma - Functional testing of 527 cancer drugs in patient-derived cancer cellsAstrid Murumägi, Daniela Ungureanu, Mariliina Arjama, et al.
Plos One|December 11, 2012
Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcomaJanne Nordberg, John Patrick Mpindi, Kristiina Iljin, et al.
BMC Genomics|March 30, 2011
A cell spot microarray method for production of high density siRNA transfection microarraysJuha K Rantala, Rami Mäkelä, Anna-Riina Aaltola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growthKristiina Iljin, Kirsi Ketola, Paula Vainio, et al.
Molecular Oncology|October 24, 2013
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growthSuvi-Katri Leivonen, Kristine Kleivi Sahlberg, Rami Mäkelä, et al.
Plos One|September 24, 2013
Plasticity of blood- and lymphatic endothelial cells and marker identificationJohannes Keuschnigg, Sirkku Karinen, Kaisa Auvinen, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Carcinogenesis|May 22, 2013
Aneuploidy facilitates oncogenic transformation via specific genetic alterations, including Twist2 upregulationGunilla Högnäs, Saara Hämälistö, Kirsi Rilla, et al.
Pageof 19